# Ramucirumab (Genetical Recombination) I.V. Infusion 100mg (サイラムザ点滴静注液１００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291429A1023). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291429A1023
- **Product name (Japanese):** サイラムザ点滴静注液１００ｍｇ
- **English title:** Ramucirumab (Genetical Recombination) I.V. Infusion 100mg
- **Active ingredient:** ラムシルマブ（遺伝子組換え）
- **Active ingredient (INN):** Ramucirumab (Genetical Recombination)
- **Strength / unit:** １００ｍｇ１０ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Eli Lilly Japan (日本イーライリリー)
- **NHI price (reference only):** JPY 76659 per １００ｍｇ１０ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291429A1023
- **JSON:** https://www.nifujipharma.com/api/drugs/4291429A1023

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Ramucirumab%20(Genetical%20Recombination)%20I.V.%20Infusion%20100mg%20(%E3%82%B5%E3%82%A4%E3%83%A9%E3%83%A0%E3%82%B6%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%E6%B6%B2%EF%BC%91%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291429A1023#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Ramucirumab (Genetical Recombination)

- [Ramucirumab (Genetical Recombination) I.V. Infusion 500mg (サイラムザ点滴静注液５００ｍｇ)](https://www.nifujipharma.com/drugs/4291429A2020) — ５００ｍｇ５０ｍＬ１瓶, Eli Lilly Japan